Temazepam for Sleep Initiation and Maintenance
Temazepam is effective for BOTH sleep initiation and sleep maintenance, though its efficacy for sleep maintenance is more robust than for sleep onset. 1
Evidence from Guidelines
The American Academy of Sleep Medicine (2017) explicitly recommends temazepam for both sleep onset AND sleep maintenance insomnia, based on moderate-quality evidence showing clinically significant improvements in both subjective sleep latency and total sleep time. 1
Key Pharmacological Characteristics
Temazepam has a relatively longer half-life (approximately 5-11 hours, longer in elderly) compared to ultra-short-acting agents like zaleplon, making it more likely to improve sleep maintenance throughout the night. 1, 2
The drug reaches peak plasma concentrations approximately 1.2-1.6 hours after dosing, which is slower than some other benzodiazepines but still adequate for addressing sleep onset when taken 30 minutes before bedtime. 3
Clinical Trial Evidence
Meta-analysis of temazepam 15 mg demonstrated reduction in subjective sleep latency that exceeded the threshold for clinical significance. 1
Meta-analysis also showed improvement in subjective total sleep time exceeding clinical significance thresholds, and one study revealed clinically significant reduction in objective wake after sleep onset (WASO). 1
FDA-approved clinical trials showed linear dose-response improvement in total sleep time, sleep latency, AND number of awakenings at doses of 7.5 mg, 15 mg, and 30 mg. 3
Comparison to Other Agents
The 2008 American Academy of Sleep Medicine guideline explicitly contrasts temazepam with ultra-short-acting agents: "Zaleplon and ramelteon have very short half-lives and consequently are likely to reduce sleep latency but have little effect on waking after sleep onset (WASO)... Eszopiclone and temazepam have relatively longer half-lives, are more likely to improve sleep maintenance." 1
Important Clinical Caveats
While temazepam addresses both sleep initiation and maintenance, some older sleep laboratory studies from the 1970s-1980s showed inconsistent effects on sleep onset, likely because the drug was absorbed too slowly to reach peak concentrations quickly enough when taken exactly at bedtime. 4, 5, 6
The recommended approach is to take temazepam 30 minutes BEFORE bedtime (not at bedtime) to allow adequate time for absorption and peak effect during the sleep onset period. 3
Temazepam is more likely to produce residual morning sedation compared to ultra-short-acting agents, though this occurs in only a minority of patients at recommended doses. 1
Dosing Recommendations
The standard starting dose is 15 mg taken 30 minutes before bedtime, which has the strongest evidence base from meta-analyses. 1
For elderly or debilitated patients, start with 7.5 mg, which has been shown to be equally effective as 15 mg for transient insomnia in clinical trials. 7
The 30 mg dose may be used for more severe insomnia but carries higher risk of residual sedation. 1, 3
Safety Considerations
Temazepam carries risks of abuse, dependence, physical withdrawal, complex sleep behaviors (sleep-driving, sleep-walking), and should be used for the shortest duration possible (typically 7-10 days). 3
The drug should only be taken when the patient can dedicate at least 7-8 hours to sleep to minimize morning impairment. 3
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be initiated before or alongside temazepam, as it demonstrates superior long-term efficacy. 1